Vasospastic complications have been reported in five patients following the use of heparin-dihydroergotamine for thrombo-embolic prophylaxis. The most important diagnostic procedure is angiography, which shows characteristic findings. Intraarterial prostaglandin is a promising form of treatment. Experience with two patients is reported.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2008-1048674 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!